Enhanced anti-melanoma efficacy through a combination of the armed oncolytic adenovirus ZD55-IL-24 and immune checkpoint blockade in B16-bearing immunocompetent mouse model

This study provides a rationale for investigation of such combination therapy in the clinic.
Source: Cancer Immunology, Immunotherapy - Category: Cancer & Oncology Source Type: research